Member Login
  1. Stocks
    2. /
  2. 4D pharma plc (LSE: DDDD)
    3. /

LSE:DDDD (4D pharma plc)

About DDDD

4d pharma PLC and its subsidiaries are in the business of research and development and production of live biotherapeutic products. The company develops biotherapeutic products for diseases such as cancer, asthma, autism, and autoimmune conditions such as arthritis and multiple sclerosis. Its developing science includes Live biotherapeutics, Microbiome, MicroRx, MicroDx, and others.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • 4D pharma plc (LSE: DDDD) Latest News

    Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
    Investing Articles

    Here’s why the 4D Pharma (LON:DDDD) share price is surging today

    | Zaven Boyrazian, MSc

    This morning, the 4D Pharma share price erupted after management made an exciting announcement - so can the stock continue…

    Read more »

    Investing Articles

    4D Pharma shares have rocketed and I’m tempted to buy now

    | Andy Ross

    4D Pharma shares leapt last week and the momentum is continuing. Given its potential game-changer drugs, it's a stock Andy…

    Read more »

    Investing Articles

    This penny stock could double in just 2 years

    | Andy Ross

    This penny stock could have a revolutionary business model with the potential to transform healthcare and I think the shares…

    Read more »

    Investing Articles

    3 trending penny shares: hit, hold or fold?

    | Joe Clark

    If I had to buy, hold or sell penny shares SYME, 4D Pharma and Novacyt, what would I do? Fool…

    Read more »

    Investing Articles

    Interested in the 4d Pharma share price? Here’s what you need to know

    | Rupert Hargreaves

    The 4d Pharma share price has surged. But is the company still worth buying after this performance, or should it…

    Read more »

    Investing Articles

    Covid-19 drug maker’s share price triples! Here’s what I’m doing now

    | Manika Premsingh

    Pharmaceutical companies like this one are bringing in Covid-19 cures. But is that enough reason to invest in them?

    Read more »

    Investing Articles

    4D pharma share price spiked under COVID-19 phase II study spotlight

    | Kirsteen Mackay

    The 4D pharma share price is fluctuating amid COVID-19 therapy speculation and positive developments in its biotherapeutic offerings.

    Read more »

    Investing Articles

    3 Neil Woodford stocks trading at massive discounts

    | G A Chester

    Should you snap up these Neil Woodford favourites at ultra-low prices?

    Read more »

    Investing Articles

    Are these two hot biotechnology shares to buy today?

    | Alan Oscroft

    Biotechnology is big business, but can you spot tomorrow's winners?

    Read more »

    Investing Articles

    Should you buy Neil Woodford’s favourite small caps Purplebricks Group plc, 4d Pharma plc and Imperial Innovations Group plc?

    | Ian Pierce

    What does the future hold for Purplebricks Group plc (LON: PURP), 4D Pharma plc (LON: DDDD) and Imperial Innovations Group…

    Read more »

    Investing Articles

    Why is Neil Woodford so bullish on drugmakers GlaxoSmithKline plc, AstraZeneca plc and 4D Pharma plc?

    | Ian Pierce

    Will GlaxoSmithKline plc (LON: GSK), AstraZeneca plc (LON: AZN) and 4D Pharma plc (LON: DDDD) be the cure for poor…

    Read more »

    Investing Articles

    Neil Woodford Buys More ‘Profoundly Undervalued’ Allied Minds PLC, 4d Pharma PLC And Midatech Pharma PLC

    | G A Chester

    Ace fund manager Neil Woodford sees huge value in Allied Minds PLC (LON:ALM), 4d Pharma PLC (LON:DDDD) and Midatech Pharma…

    Read more »